PrimeCell Therapeutics LLC
Stem cell engineering
PrimeCell Therapeutics, a subsidiary of PrimeGen Biotech LLC, is headquartered in Irvine, California.
Thomas C.K. Yuen, Chairman & CEO
Steven D. Gershick, CFO
213 Technology Drive
Irvine, CA 92618
USA
Phone: +1-949-428-0500
Fax: +1-949-727-3875
PrimeCell Therapeutics’s technology is basec on the PrimeCell™ platform technology for modern stem stell engineering. This technology can be used to reprogramme germ-line stem cells, restoring their pluripotent properties. Specific cell lines have already been established and cover applications for the regeneration of heart muscles, cartilage, bone, skin and other tissues.
Related patents
- Stem Cell Maturation for All Tissue Types
- Therapeutic Reprogramming, Hybrid Stem Cells and Maturation
- Adipose-derived Stem Cells for Tissue Regeneration and Wound Healing
- Therapeutic Reprogramming of Germ Line Stem Cells
- Use of Nuclear Material to Therapeutically Reprogram Differentiated Cells
- Therapeutic Reprogramming of Germ Line Stem Cells
- Stem Cell Maturation for All Tissue Lines
- Therapeutic Reprogramming, Hybrid Stem Cells and Maturation